Skip to main content
. 2019 May 31;14(5):e0217535. doi: 10.1371/journal.pone.0217535

Table 3. Comparison of quality of life between two groups (Q2(Q1-Q3)).

Variable Before the intervention 1 month after discharge 6 months after discharge
Intervention group (n = 70) Control group
(n = 70)
P
Value
Intervention group (n = 70) Control group (n = 70) P Value Intervention group (n = 70) Control group
(n = 70)
P Value
Symptoms 17.86(12.50–26.79) 15.46(10.41–20.52) 0.081 100.00(82.13–100.0) 83.01(73.21–100.0) 0.093 100.00(100.0–100.0) 100.00(81.97–100.0) 0.002**
Physical function 21.88(0.0–31.25) 15.63(4.69–25.00) 0.250 93.75(87.5–100.0) 93.75(87.50–93.75) 0.012* 100.00(93.75–100.0) 93.75(93.75–100.0) 0.004**
Psychosocial function 25.00(3.57–35.71) 17.86(8.93–44.64) 0.972 54.46(46.43–60.71) 37.50(32.14–46.42) 0.000** 75.00(62.50–85.71) 60.71(50.0–75.0) 0.007**
Cognitive function 60.00(40.0–73.33) 60.00(40.0–60.0) 0.078 73.33(60.0–86.67) 60.00(60.00–60.00) 0.000** 80.00(60.0–100.0) 80.00(60.0–80.0) 0.025*
Adverse reactions 45.83(37.5–50.00) 41.67(25.0–58.33) 0.737 100.00(100.0–100.0) 100.00(100–100) 0.500 100.00(95.83–100.0) 100.00(100.0–100.0) 0.018*
Treatment satisfaction 51.39(47.22–56.94) 51.39(51.39–54.51) 0.281 83.33(66.67–100.0) 62.50(55.20–62.50) 0.000** 100.00(95.83–100.0) 66.67(62.50–92.71) 0.000**
Total score 211.51(182.45–248.87) 201.51(173.63–229.52) 0.067 484.81±52.91 432.49±34.99 0.000** 544.29(5509.99–568.04) 494.33(455.97–530.15) 0.000**

* P<0.05

**P<0.01